beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Stephen Kay Elected Chair of BIDMC Board

New members named as trustees, overseers

BOSTON - Stephen B. Kay of Chestnut Hill, a Senior Director of Goldman Sachs & Co, has been named as the fifth Chair of the Board of Directors of Beth Israel Deaconess Medical Center.

He succeeds Lois E. Silverman, who is stepping down after four years as chair and who will become a trustee for life.

Kay has been an important member of the lay leadership of the medical center for well over a decade. He served as Board Chair of Beth Israel Hospital from 1994-96 and became the founding Board Chair of CareGroup Health Systems, the holding company of BIDMC, in 1996. He has continued to serve on the BIDMC Board of Directors .

"With so many talented people on our board, it is a great honor for me to be named chair," said Kay. "BIDMC is a very special place, with a well deserved reputation for clinical excellence and compassionate care. While these are challenging times in health care, I intend to keep us focused on being a national leader in quality and safety."

"We are quite fortunate to have had someone of Steve's caliber involved in the medical center for so long," said Paul Levy, BIDMC's President and CEO. "His business acumen, combined with his enormous capacity to give back to organizations he believes in, is unparalleled."

The transition of Board Chairs took place at BIDMC's Annual Meeting on Tuesday evening. The agenda included the re-election of Harriet Lewis, Virginia MacDowell and Jack Manning to the 21-member Board of Directors. The meeting also saw the election of nine new members to the Board of Trustees and 16 new members to the Board of Overseers.

Since retiring from Goldman Sachs as a limited partner, Kay has devoted himself largely to a variety of investment and not-for-profit activities.

As a member of the BIDMC Board of Directors, Kay has served on the campaign leadership, governance and nominating committees. In addition, he served as chairman of the Board of Trustees of Brandeis University from 2001 to 2007 and remains as chairman of the budget and finance committee.

Kay has been a trustee of the Dana-Farber Cancer Institute since 1981. Formerly treasurer of Dana-Farber, he now serves as chairman of the investment committee and as a member of the executive and finance committees.

He is a founding director of Tenacity, a tennis/academic program for inner-city youth, and a vice chairman of the Boston Symphony Orchestra. At Harvard, Kay served on the Board of Overseers from 1994 to 1999. He was formerly chairman of the visiting committee at the Harvard School of Public Health and is presently a member of the Dean's Advisory Council. He also serves on the Committee on University Resources.

Kay is a past president of the Harvard Business School Association of Boston. He is also a former director of the Controlled Risk Insurance Company, Harvard's captive insurance company.

The meeting also saw the election of nine new members of the Board of Trustees and 16 new members of the Board of Overseers

Trustees serve as advisors to the board of directors and officers of BIDMC. Trustees serve on committees of the board of directors and identify and involve potential supporters and resources for programs and facilities of the medical center, among other responsibilities.

The new trustees are: Beverly Edgehill, EdD, of Natick; Steven Flier, MD, of Newton; Mary Ellen Grossman of Waban; Susan C. Kaplan of West Newton; Mark Leuchtenberger of Newton; Margaret McKenna of Boston; David R. Roberts, MD of Newton; Jeffrey D. Saffitz, MD, PhD, of Waban; and Robert Sherman of Needham Heights.

Irving Fox MD of Wellesley joins Silverman as a new trustee for life.

The members of the board of overseers act as good-will ambassadors within the communities served by the medical center. The overseers highlight the importance of BIDMC's mission to their local communities and strengthen the medical center's ability to advance its mission through philanthropy.

The new overseers are: Rashid Ashraf of Wellesley; Jonathan Bornstein of Newton Highlands; Karen Bressler of Jamaica Plan; Mark deLaar of Norwell; Tom DeSimone of Boston; Peter Finn of Needham; Danielle Remis Hackel of Brookline; Gordon Kluzak of Boston; Scott Krentzman of West Newton; Renee Landers of Watertown; Andrew W. Lo of Weston; J. Keith Motley, PhD, of Boston; Ravikanth Pappu of Cambridge; Sarah Salter Levy of Weston and Stuart FL; David Schechter of Chestnut Hill, Keith Sykes of Milton and Tracey West of Milton.

Laurel E. Friedman of Brookline; Jane L. Holtz of West Falmouth; Shirley G. Libby of Boston and Key Biscayne FL; and Eleanor Lowry of Chelsea have been named overseers for life.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and consistently ranks among the top four in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit .